Moderna Inc
U.S. health officials brace for another fall Covid surge, but with fewer deaths
People walk past a COVID-19 walk up testing site on July 28, 2022 in New York City. Liao Pan | China News Service | Getty Images Fall is on the horizon and public health officials are again bracing for another wave of Covid cases. Over the past two years, fall and winter have brought devastating […]
Read More
Shares creating the most important moves premarket: Catalent, Pinduoduo, Netflix and many others
In this post WMT PDD NFLX CTLT MRNA ETSY Video1:3601:36 News Update – Pre-Markets News Briefing Check out the businesses producing headlines prior to the bell: Catalent (CTLT) – The drug supply and producing technological know-how organization conquer base line estimates for its most up-to-date quarter. Nevertheless, its revenue was brief of Wall Street forecasts, […]
Read More
Moderna sues Pfizer/BioNTech for patent infringement about Covid vaccine
The Moderna Covid-19 vaccine awaits administration at a vaccination clinic in Los Angeles, California on December 15, 2021. Frederic J. Brown | AFP | Getty Visuals Moderna is suing Pfizer and its German spouse BioNTech for patent infringement in the enhancement of the initial Covid-19 vaccine permitted in the United States, alleging they copied technologies […]
Read More
FDA plans to authorize bivalent boosters by Labor Day, sources say
In this photo illustration, vials and a medical syringe seen in front of the Food and Drug Administration (FDA) of the United States and Pfizer Pharmaceutical company logos. FDA approves Pfizer/BioNTech the COVID-19 coronavirus vaccine for emergency use in the US, reportedly by media. Pavlo Gonchar | AP The Food and Drug Administration plans to […]
Read More
FDA authorizes emergency use for Novavax Covid-19 vaccine for ages 12 and 17
A box of the Novavax Covid-19 vaccine arranged at a pharmacy in Schwenksville, Pennsylvania, US, on Monday, Aug. 1, 2022. Bloomberg | Bloomberg | Getty Images Biotechnology company Novavax announced on Friday that its Covid-19 vaccine has been authorized for emergency use by the U.S Food and Drug Administration for adolescents between the ages of […]
Read More
Stocks making the biggest moves midday: Disney, Poshmark, Vroom and more
Disney World celebrated its 50th anniversary in April 2022. Aaronp/bauer-griffin | Gc Images | Getty Images Check out the companies making headlines in midday trading Monday. Poshmark — Shares of the secondhand fashion retailer jumped 15% after Barclays upgraded them to overweight from equal weight. The firm said it sees more than 40% potential upside for the […]
Read More
UK becomes the first country to approve a dual Covid vaccine targeting omicron
Britain has become the first country in the world to approve Moderna’s bivalent Covid-19 vaccine, which targets both the original strain of the virus and the newer Omicron variant. Long Visual Press | Universal Images Group | Getty Images LONDON — Britain on Monday became the first country in the world to approve a dual […]
Read More
Stocks making the biggest moves midday: Gilead Sciences, CVS, Electronic Arts and more
A customer walks towards the entrance of a CVS Health Corp. store in downtown Los Angeles, California, U.S., on Friday, Oct. 27, 2017. Christopher Lee | Bloomberg | Getty Images Check out the companies making headlines in midday trading Wednesday. Gilead Sciences — Shares of the biopharma company rose 6.6% after quarterly revenue of $6.26 […]
Read More
Stocks making the biggest moves premarket: CVS, Under Armour, Moderna and more
Check out the companies making headlines before the bell: CVS Health (CVS) – The drugstore operator and pharmacy benefits manager saw its shares rise 3.8% in the premarket after beating top- and bottom-line estimates and raising its full-year earnings forecast. Results were helped by strong sales of over-the-counter Covid-19 tests as well as an upbeat […]
Read More
Moderna’s 2Q earnings beat expectations, but it writes off $500 million in expiring Covid shots
Illustration of a vial of Moderna vaccine for coronavirus treatment. Marcos Del Mazo | Lightrocket | Getty Images Moderna on Wednesday reported second quarter results that beat earnings and revenue expectations driven $4.5 billion in sales from its Covid -19 vaccine, but it’s still the company’s only commercially available product and it took a big […]
Read More